470 related articles for article (PubMed ID: 18602439)
1. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z
Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.
Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z
Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
[TBL] [Abstract][Full Text] [Related]
4. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
5. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
6. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
7. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.
Zhu D; Jiang S; Luo X
Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938
[TBL] [Abstract][Full Text] [Related]
9. Novel prophylactic and therapeutic vaccine against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.
Ha SJ; Jeon BY; Kim SC; Kim DJ; Song MK; Sung YC; Cho SN
Gene Ther; 2003 Sep; 10(18):1592-9. PubMed ID: 12907951
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
13. [Immunity characteristics induced by a genetic vaccine expressing Ag85B-ESAT6 fusion protein].
Shi CH; Wang XW; Zhu DS; Xu ZK; Bai YL; Xue Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):777-80. PubMed ID: 16324275
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and Bacillus Galmette-Guérin.
Dou J; Tang Q; Zhao F; Chu L; Chen J; Cao M; Liu C; Wang Y; Li Y; Li JL
Immunol Invest; 2008; 37(2):113-27. PubMed ID: 18300037
[TBL] [Abstract][Full Text] [Related]
15. Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response.
Wang D; Xu J; Feng Y; Liu Y; Mchenga SS; Shan F; Sasaki J; Lu C
Vaccine; 2010 Apr; 28(18):3134-42. PubMed ID: 20197133
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of protective efficacy of two tuberculosis DNA vaccines by lung histopathological analysis].
Wu X; Yao G; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Nov; 35(6):384-6. PubMed ID: 11840765
[TBL] [Abstract][Full Text] [Related]
17. Novel constructs of tuberculosis gene vaccine and its immune effect on mice.
Dou J; Chen JS; Wang J; Chen GB; Zhao FS; Tang Q; Fang XS; Chu LL; Pan M
Cell Mol Immunol; 2005 Feb; 2(1):57-62. PubMed ID: 16212912
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
19. Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice.
Liang Y; Bai X; Zhang J; Song J; Yang Y; Yu Q; Li N; Wu X
Mol Med Rep; 2016 Aug; 14(2):1146-52. PubMed ID: 27279275
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
